Formosa Optical Technology Co.,Ltd. (TPEX:5312)
Taiwan · Delayed Price · Currency is TWD 109.50
-0.50 (-0.45%)
Sep 18, 2025, 12:33 PM CST
TPEX:5312 Revenue
Formosa Optical Technology had revenue of 960.35M TWD in the quarter ending June 30, 2025, with 0.56% growth. This brings the company's revenue in the last twelve months to 3.95B, up 0.23% year-over-year. In the year 2024, Formosa Optical Technology had annual revenue of 3.97B with 2.80% growth.
Revenue (ttm)
3.95B
Revenue Growth
+0.23%
P/S Ratio
1.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.97B | 108.21M | 2.80% |
| Dec 31, 2023 | 3.86B | 565.98M | 17.16% |
| Dec 31, 2022 | 3.30B | 384.55M | 13.20% |
| Dec 31, 2021 | 2.91B | -148.72M | -4.86% |
| Dec 31, 2020 | 3.06B | -154.27M | -4.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lumosa Therapeutics | 37.25M |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Center Laboratories | 1.60B |